Yong Zeng,
Associate Professor,
University of Florida
Dr. Zeng is an associate professor of chemistry and affiliate faculty of Biomedical Engineering at the University of Florida, and a member of UF Health Cancer Center. He obtained his PhD in Chemistry from University of Alberta, Canada and completed the postdoc training at University of California, Berkeley. Dr. Zeng’s research draws on chemistry, nanomaterials, bioengineering, and medicine to develop innovative micro and nanoscale tools to advance precision medicine of cancer. His technology innovations span from biomolecular assays to micro/nano systems for sensitive measurements of liquid biopsies and molecular biomarkers. His group is also devoted to translational research to bring the technological innovations to clinical sciences, closely collaborating with biologists and clinicians. Dr. Zeng is internationally recognized for his pioneering research in developing microfluidic technologies for isolation and analysis of tumor-derived extracellular vesicles (EVs) for cancer diagnostics and therapeutics. His research programs have been continuously funded by NIH and other funding agencies and led to many highly visible publications on top-tier journals, including Nat. Biomed. Eng. and Sci. Transl. Med., which were featured in public media outlets such as the NIH Director’s Blog and the JAMA Network.
High-Performance Biomarker Analysis Using Microfluidic Technology
Thursday, 18 September 2014 at 10:15
Add to Calendar ▼2014-09-18 10:15:002014-09-18 11:15:00Europe/LondonHigh-Performance Biomarker Analysis Using Microfluidic TechnologyLab-on-a-Chip, Microfluidics and Microarray World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Microfluidics has emerged as a new paradigm in quantitative measurements of biomolecules and dynamic pathways across radically different spatiotemporal scales. In this presentation, I will share our research on developing microfluidics-based biotechnologies for quantitative analysis of cancer biomarkers, including bead-based digital PCR, actuatable microwell-patterned ELISA, and integrated microvesicle capture and analysis microsystem. Their applications to biomedical analyses of genetic mutations, protein biomarkers, and circulating exosomes derived from cancer patients will be discussed.
Add to Calendar ▼2014-09-18 00:00:002014-09-19 00:00:00Europe/LondonLab-on-a-Chip, Microfluidics and Microarray World CongressLab-on-a-Chip, Microfluidics and Microarray World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com